NCT06234735

Brief Summary

Patients with lung cancer have poor physical activity and increased sedentary behavior, with the presence of high levels of fatigue. A randomized controlled trial will be carried out to compare usual care versus a personalized exercise program in the community, in order to explore the changes on physical activity and sedentary behavior and its impact on cancer-related fatigue.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable lung-cancer

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

January 31, 2024

Completed
15 days until next milestone

Study Start

First participant enrolled

February 15, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2025

Completed
Last Updated

February 9, 2024

Status Verified

February 1, 2024

Enrollment Period

1.3 years

First QC Date

September 8, 2023

Last Update Submit

February 7, 2024

Conditions

Keywords

Physical activityCommunityPhysiotherapy

Outcome Measures

Primary Outcomes (2)

  • Physical Activity

    Level of daily physical activity measured with accelerometry. Accelerometry will be worn by patients for 7 consecutive days and will measure the time in minutes spent in low (1.6 - \<3 METs), moderate (3.0 - \<6.0 METs) and vigorous (⩾6 METs) physical activities.

    7 consecutive days, before and after intervention (6 months)

  • Sedentarism

    Weekly sedentary behavior measured with the Sedentary Behaviour Questionnaire (SBQ). The SBQ measures the time in minutes spent in 9 different sedentary activities during a week, differentiating working days and week-ends. The score is the separately sum of the hours per day for week days and week-end days. A higher score is indicative of longer time spent in sitting and therefore an indication of higher sedentarism.

    Before and after intervention (6 months)

Secondary Outcomes (12)

  • Walking distance

    Before and after intervention (6 months)

  • 1-minute Sit-to-Stand test

    Before and after intervention (6 months)

  • Pulmonary function

    Before and after intervention (6 months)

  • Dyspnea

    Before and after intervention (6 months), and once a week during intervention.

  • Cancer Quality of Life Questionnaire

    Before and after intervention (6 months).

  • +7 more secondary outcomes

Other Outcomes (2)

  • Daily dyspnea

    Before and after each physical activity session, minimum 3 sessions per week, during the intervention period (6 months).

  • Steps per day

    Once a week during intervention (6 months)

Study Arms (2)

Control Group

ACTIVE COMPARATOR

The control group will follow the conventional protocol established by the Catalan Institute of Oncology (ICO) for the treatment of lung cancer. In addition, physical activity guidelines will be recommended with the aim of encouraging patients to lead a more active life that helps them improve their physical capabilities. The research team will meet individually with participants in the control group and inform them about the importance of physical activity, motivating them to practice regularly.

Behavioral: Conventional intervention

Experimental Group

EXPERIMENTAL

Motivational interviews will be used to help identify individual motivations, barriers, and preferences towards physical activity (PA). Objectives and personalized exercise regimens (e.g. walking, cycling, nordic walking) with a person-centered approach. Patients will engage in a minimum of 3 PA sessions/week (45min each) for 6 months, reporting via a phone app. Weekly patient-reported outcome measures (PROMs) will track progress. The first 3 months involve group sessions for instruction and correction; the last 3 months include one monthly in-person session combining resistance and aerobic training, with a duration of 1.5 hours. To drive behavior change, personalized weekly challenges will be presented.

Behavioral: Physical activity in the community

Interventions

Supervised and guided PA sessions in the community setting using public resources such as parks, sports facilities, etc.

Experimental Group

Conventional protocol for lung cancer and PA recommendations.

Control Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with a diagnosis of non-small cell lung cancer who are candidates for radical and/or metastatic treatment
  • ages between 18 and 70
  • ability to answer questionnaires in Spanish
  • who have accepted participation and signed the informed consent

You may not qualify if:

  • participants with a life expectancy of less than 6 months
  • patients with levels of physical activity greater than 240 metabolic equivalents (MET) METs/day
  • patients who have a contraindication to exercise
  • patients with dementia or spatial disorientation or behavioral disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Blanquerna Health Science Faculty

Barcelona, 08025, Spain

Location

MeSH Terms

Conditions

Lung NeoplasmsSedentary BehaviorFatigueMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesBehaviorSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jordi Teixido, PhD

    University Ramon Llull

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The investigator and the professional who will do the statistical analyses, will be blinded to the group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2023

First Posted

January 31, 2024

Study Start

February 15, 2024

Primary Completion

May 31, 2025

Study Completion

October 31, 2025

Last Updated

February 9, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations